November 20, 2020
(ABC News) – Pfizer and partner BioNTech announced they will submit a request on Friday to the U.S. Food and Drug Administration for emergency use authorization of their COVID-19 vaccine candidate. The submission, which is based on a vaccine efficacy … Read More
November 19, 2020
(Axios) – As the science of brain-computer interfaces (BCI) and other neurotechnologies progresses, researchers are calling for ethical guidelines to be established now — before the technology fully matures. Why it matters: We’re still far away from technologies that fully … Read More
November 18, 2020
(Nature) – In September 2019, four researchers wrote to the publisher Wiley to “respectfully ask” that it immediately retract a scientific paper. The study, published in 2018, had trained algorithms to distinguish faces of Uyghur people, a predominantly Muslim minority … Read More
November 17, 2020
(Associated Press) – If those early results hold up and U.S. regulators agree the shots are safe, emergency use of small, rationed supplies could start in late December. Other countries with contracts for early doses would undertake their own reviews. … Read More
November 13, 2020
(Associated Press) – Microsoft said it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine researchers. It said in a blog post Friday that most of the attacks in … Read More
November 12, 2020
(Science) – Another day, another promising COVID-19 vaccine? A Russian institute announced today its vaccine candidate has had remarkable success in an efficacy trial, just 2 days after the widely celebrated news from Pfizer and BioNTech that their vaccine had greater … Read More
November 10, 2020
(STAT News) – But what the companies share may be bigger than their differences: Both are banking on a genetic technology that has long held huge promise but has so far run into biological roadblocks. It is called synthetic messenger … Read More
November 10, 2020
(New York Times) – Brazil said on Monday that it had halted a late-stage trial of a Chinese vaccine that had been considered a global front-runner in the race to develop a protective shot for the coronavirus after a “serious … Read More
November 6, 2020
(Wired) – Crispr routinely makes headlines. To the degree that people are even aware that life can be edited, it’s this technique they tend to reference. But Crispr, while powerful, is problematic: Scientists can’t directly see the changes they’re making … Read More
November 5, 2020
(Science) – Science has learned that both FDA’s decision and the EU deal came about under unusual circumstances that gave the company important advantages. FDA never consulted a group of outside experts that it has at the ready to weigh … Read More
